[1]The human gut microbiota in IBD, characterizing hubs, the core microbiota and terminal nodes: a network-based approach
- PMID: 40571931
- PMCID: PMC12199529
- DOI: 10.1186/s12866-025-04106-0
[1]The human gut microbiota in IBD, characterizing hubs, the core microbiota and terminal nodes: a network-based approach
Abstract
Background: Dysbiosis, an imbalance in the bacterial composition of the human gut microbiota, is linked to inflammatory bowel disease (IBD). Advances in biological techniques have generated vast microbiota datasets, presenting both opportunities and challenges for clinical research in that field. Network theory offers powerful tools to analyze these complex datasets.
Methods: Utilizing genetically unrelated individuals from the Kiel IBD-KC cohort, we compared network properties of the gut microbiota between patients with inflammatory bowel disease (IBD, n = 522) and healthy controls (n = 365), and between Crohn's disease (CD, n = 230) and Ulcerative Colitis (UC, n = 280). Correlation-based microbial networks were constructed, with genera as nodes and significant pairwise correlations as edges. We used centrality measures to identify key microbial constituents, called hubs, and suggest a network-based definition for a core microbiota. Using Graphlet theoretical approaches, we analyzed network topology and individual node roles.
Results: Global network properties differed between cases and controls, with controls showing a potentially more robust network structure characterized by e.g., a greater number of components and a lower edge density. Local network properties varied across all groups. For cases and both UC and CD, Faecalibacterium and Veillonella, and for unaffected controls Bacteroides, Blautia, Clostridium XIVa, and Clostridium XVIII emerged as unique hubs in the respective networks. Graphlet analysis revealed significant differences in terminal node orbits among all groups. Four genera which act as hubs in one state, were found to be terminal nodes in the opposite disease state: Bacteroides, Clostridium XIVa, Faecalibacterium, and Subdoligranulum. Comparing our network-based core microbiota definition with a conventional one showed an overlap in approximately half of the core taxa, while core taxa identified through our new definition maintained high abundance.
Conclusion: The network-based approach complements previous investigations of alteration of the human gut microbiota in IBD by offering a different perspective that extends beyond a focus solely on highly abundant taxa. Future studies should further investigate functional roles of hubs and terminal nodes as potential targets for interventions and preventions. Additionally, the advantages of the newly proposed network-based core microbiota definition, should be investigated more systematically.
Keywords: Centrality measures; Core microbiota; Graphlets; Gut microbiota; Hub and terminal nodes; Inflammatory bowel disease; Network analysis.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Written informed consent was obtained from each included participant. Study protocols conform to the ethical guidelines of the 1975 Declaration of Helsinki and have been priorly approved by the local ethics committee of the Medical Faculty at Kiel University, Germany (AZ 117/13). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures










Similar articles
-
Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics.Front Cell Infect Microbiol. 2025 Jul 1;15:1595884. doi: 10.3389/fcimb.2025.1595884. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40667420 Free PMC article.
-
Patient education interventions for the management of inflammatory bowel disease.Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2. Cochrane Database Syst Rev. 2023. PMID: 37172140 Free PMC article.
-
Deciphering the microbiome-metabolome landscape of an inflammatory bowel disease inception cohort.Gut Microbes. 2025 Dec;17(1):2527863. doi: 10.1080/19490976.2025.2527863. Epub 2025 Jul 18. Gut Microbes. 2025. PMID: 40679059 Free PMC article.
-
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2. Cochrane Database Syst Rev. 2021. PMID: 34844288 Free PMC article.
-
The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis.Scand J Gastroenterol. 2016 Dec;51(12):1407-1415. doi: 10.1080/00365521.2016.1216587. Epub 2016 Aug 9. Scand J Gastroenterol. 2016. PMID: 27687331
References
-
- Torres J, Mehandru S, Colombel J-F, Peyrin-Biroulet L. Crohn’s disease. The Lancet. 2017;389:1741–55. - PubMed
-
- Le Berre C, Ananthakrishnan AN, Danese S, Singh S, Peyrin-Biroulet L. Ulcerative Colitis and Crohn’s Disease Have Similar Burden and Goals for Treatment. Clin Gastroenterol Hepatol. 2020;18:14–23. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources